200 related articles for article (PubMed ID: 36352741)
1. Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma
Wang J; Li M; Jin L; Guo P; Zhang Z; Zhanghuang C; Tan X; Mi T; Liu J; Wu X; Wei G; He D
Drug Deliv; 2022 Dec; 29(1):3291-3303. PubMed ID: 36352741
[TBL] [Abstract][Full Text] [Related]
2. Exosome mimetics derived from bone marrow mesenchymal stem cells ablate neuroblastoma tumor in vitro and in vivo.
Li M; Wang J; Guo P; Jin L; Tan X; Zhang Z; Zhanghuang C; Mi T; Liu J; Wang Z; Wu X; Wei G; He D
Biomater Adv; 2022 Nov; 142():213161. PubMed ID: 36308859
[TBL] [Abstract][Full Text] [Related]
3. A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.
Wei H; Chen J; Wang S; Fu F; Zhu X; Wu C; Liu Z; Zhong G; Lin J
Int J Nanomedicine; 2019; 14():8603-8610. PubMed ID: 31802872
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis.
Wei H; Chen F; Chen J; Lin H; Wang S; Wang Y; Wu C; Lin J; Zhong G
Int J Nanomedicine; 2022; 17():3483-3495. PubMed ID: 35959282
[TBL] [Abstract][Full Text] [Related]
5. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer.
Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived mesenchymal stem cell-derived exosomal microRNA-208a promotes osteosarcoma cell proliferation, migration, and invasion.
Qin F; Tang H; Zhang Y; Zhang Z; Huang P; Zhu J
J Cell Physiol; 2020 May; 235(5):4734-4745. PubMed ID: 31637737
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA PVT1 encapsulated in bone marrow mesenchymal stem cell-derived exosomes promotes osteosarcoma growth and metastasis by stabilizing ERG and sponging miR-183-5p.
Zhao W; Qin P; Zhang D; Cui X; Gao J; Yu Z; Chai Y; Wang J; Li J
Aging (Albany NY); 2019 Nov; 11(21):9581-9596. PubMed ID: 31699956
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
Li Y; Hou H; Zhang P; Zhang Z
Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow mesenchymal stem cells and their derived exosomes resolve doxorubicin-induced chemobrain: critical role of their miRNA cargo.
El-Derany MO; Noureldein MH
Stem Cell Res Ther; 2021 Jun; 12(1):322. PubMed ID: 34090498
[TBL] [Abstract][Full Text] [Related]
10. Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p.
Zhuang L; Xia W; Chen D; Ye Y; Hu T; Li S; Hou M
J Nanobiotechnology; 2020 Oct; 18(1):157. PubMed ID: 33129330
[TBL] [Abstract][Full Text] [Related]
11. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.
Qiu R; Sun D; Bai Y; Li J; Wang L
Drug Deliv; 2020 Nov; 27(1):1704-1717. PubMed ID: 33305647
[TBL] [Abstract][Full Text] [Related]
12. Exosomal Micro-RNA-96 Derived From Bone Marrow Mesenchymal Stem Cells Inhibits Doxorubicin-Induced Myocardial Toxicity by Inhibiting the Rac1/Nuclear Factor-κB Signaling Pathway.
Lei B; Wu X; Xia K; Sun H; Wang J
J Am Heart Assoc; 2021 Sep; 10(17):e020589. PubMed ID: 34459233
[TBL] [Abstract][Full Text] [Related]
13. Transfer of exosomal microRNAs confers doxorubicin resistance in osteosarcoma cells.
Cai T; Zhang C; Zhan T
Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36866739
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin and CD‑CUR inclusion complex co‑loaded in thermosensitive hydrogel PLGA‑PEG‑PLGA localized administration for osteosarcoma.
Yang Z; Liu J; Lu Y
Int J Oncol; 2020 Aug; 57(2):433-444. PubMed ID: 32468050
[TBL] [Abstract][Full Text] [Related]
15. Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma.
Liu Y; Raina DB; Sebastian S; Nagesh H; Isaksson H; Engellau J; Lidgren L; Tägil M
Acta Biomater; 2021 Sep; 131():555-571. PubMed ID: 34271171
[TBL] [Abstract][Full Text] [Related]
16. Activation of Dynamin-Related Protein 1 and Induction of Mitochondrial Apoptosis by Exosome-Rifampicin Nanoparticles Exerts Anti-Osteosarcoma Effect.
Chen W; Lin W; Yu N; Zhang L; Wu Z; Chen Y; Li Z; Gong F; Li N; Chen X; He X; Wu Y; Zeng X; Yueh Y; Xu R; Ji G
Int J Nanomedicine; 2022; 17():5431-5446. PubMed ID: 36426375
[TBL] [Abstract][Full Text] [Related]
17. Generation of Small RNA-Modulated Exosome Mimetics for Bone Regeneration.
Fan J; Lee CS; Kim S; Chen C; Aghaloo T; Lee M
ACS Nano; 2020 Sep; 14(9):11973-11984. PubMed ID: 32897692
[TBL] [Abstract][Full Text] [Related]
18. Exosomes Derived from Human Bone Marrow Mesenchymal Stem Cells Promote Tumor Growth Through Hedgehog Signaling Pathway.
Qi J; Zhou Y; Jiao Z; Wang X; Zhao Y; Li Y; Chen H; Yang L; Zhu H; Li Y
Cell Physiol Biochem; 2017; 42(6):2242-2254. PubMed ID: 28817816
[TBL] [Abstract][Full Text] [Related]
19. The promising roles of exosomal microRNAs in osteosarcoma: A new insight into the clinical therapy.
Tian W; Niu X; Feng F; Wang X; Wang J; Yao W; Zhang P
Biomed Pharmacother; 2023 Jul; 163():114771. PubMed ID: 37119740
[TBL] [Abstract][Full Text] [Related]
20. Melatonin and doxorubicin co-delivered via a functionalized graphene-dendrimeric system enhances apoptosis of osteosarcoma cells.
Niu G; Yousefi B; Qujeq D; Marjani A; Asadi J; Wang Z; Mir SM
Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111554. PubMed ID: 33321618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
